Aldeyra Therapeutics Inc/ US01438T1060 /
03.05.2024 22:00:00 | Diff. -0,0500 | Volumen | Geld01:02:28 | Brief01:02:28 | Tageshoch | Tagestief |
---|---|---|---|---|---|---|
4,1600USD | -1,19% | 319.625 Umsatz: 1,15 Mio. |
3,9100Geld Vol: 500 | 4,2700Brief Vol: 200 | 4,2900 | 4,0750 |
GlobeNewswire
19:48
Studies Presented at AUA 2024 Highlight Latest Research on Voiding Dysfunction and BPH
GlobeNewswire
19:04
AKRO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Th...
GlobeNewswire
18:44
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Northern Genesis Acquisition Corp. n/k/a The Lion Electri...
GlobeNewswire
18:12
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investor...
GlobeNewswire
17:06
MS INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Morgan Stanley Investors to Inquire ...
GlobeNewswire
16:47
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
16:30
NASDAQ: ADSK: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Law...
GlobeNewswire
15:58
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Befo...
GlobeNewswire
15:55
INVESTOR DEADLINE APPROACHING: Robbins Geller Rudman & Dowd LLP Announces that The Chemours Company ...
GlobeNewswire
15:45
GoodRx Holdings, Inc. (GDRX) Investors: June 21, 2024 Filing Deadline in Securities Class Action - C...
GlobeNewswire
15:44
ROSEN, A TOP RANKED LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Act...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite